Dermal

SNAP-8

Acetyl octapeptide-3

SNAP-8 is associated with the cosmetic ingredient name acetyl octapeptide-3. Reference identifiers need care: similarly named database records do not necessarily encode the same structure.

Reviewed September 2026

Residues
8. verified: 8 residues; N-acetyl and C-terminal amide groups are modifications, not additional residues.
Average mass
1,075.2 Da. verified: Reference form: Acetyl octapeptide-3 reference Ac–EEMQRRAD–NH2 (PubChem CID 76283482); named SNAP-8 here. Alternative synonym records do not establish lot identity.; formula C41H70N16O16S. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement.
pI
Not established. unverified: No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH.

Reference details

Reference details
Residues8
Average mass1,075.2 Da
pINot established
Identity
AliasesAcetyl octapeptide-3
Research areaDermal

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

Acetyl octapeptide-3 reference Ac–EEMQRRAD–NH2 (PubChem CID 76283482); named SNAP-8 here. Alternative synonym records do not establish lot identity. Reference only, not a sold-lot measurement.

  • Residues: 8 (verified). 8 residues; N-acetyl and C-terminal amide groups are modifications, not additional residues. Residues source 1 Residues source 2
  • Average mass: 1,075.2 Da (verified). Reference form: Acetyl octapeptide-3 reference Ac–EEMQRRAD–NH2 (PubChem CID 76283482); named SNAP-8 here. Alternative synonym records do not establish lot identity.; formula C41H70N16O16S. PubChem average molecular weight, not monoisotopic mass. Excludes unlisted counterions, solvent and formulation ingredients; not a sold-lot measurement. Average mass source 1
  • pI: Not established (unverified). No documented pI or validated full modification-aware ionization model was established for this exact reference form. Terminal chemistry, noncanonical residues, lipidation, cyclization or non-alpha linkages cannot be silently omitted. Not formulation pH. pI source 1

Reference scope and linked records

Reference type: Modified peptide.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: SNAP-8. The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. Ji et al. (2020): Method development for acetyl octapeptide-3 analysis by liquid chromatography-tandem mass spectrometry. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
  2. PubChem: acetyl octapeptide-3, CID 76283482. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
  3. PubChem: alternative SNAP-8 synonym record, CID 71587832. Source for the chemistry or study context discussed above; not an Aminos lot certificate.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About SNAP-8

Identity and context

Acetylation and the terminal chemistry form part of the identity. PubChem contains differently structured records carrying acetyl octapeptide-3 naming, so this page does not select a supplier structure from the trade name alone or assign an unverified calculated mass.

Reference classification

Modified peptide. The linked catalogue product is SNAP-8. This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Match the full structural specification to a stated identifier before using molecular properties. For lot testing, distinguish identification, amount and impurity profiling; these are different analytical questions.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesA primary analytical-method paper developed liquid chromatography–tandem mass spectrometry for acetyl octapeptide-3. Its method-development focus is useful when assessing an identity and quantification claim. Descriptive cosmetic claims in an introduction are not equivalent to a clinical comparison performed by that study.Source context
What cannot be inferredA chemical database entry or an assay method does not prove wrinkle reduction, equivalence to botulinum toxin, or safety by any administration route. Evidence from a finished cosmetic preparation would also be formulation-specific.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. Ji et al. (2020): Method development for acetyl octapeptide-3 analysis by liquid chromatography-tandem mass spectrometryPrimary source for the reference discussion; not lot-specific product evidence.
  2. PubChem: acetyl octapeptide-3, CID 76283482Primary source for the reference discussion; not lot-specific product evidence.
  3. PubChem: alternative SNAP-8 synonym record, CID 71587832Primary source for the reference discussion; not lot-specific product evidence.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.